🇺🇸 FDA
Patent

US 10588907

Methods and compositions for inhibiting the interaction of menin with MLL proteins

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 10588907 (Methods and compositions for inhibiting the interaction of menin with MLL proteins) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/541, A61P